The diagnosis of this aggressive non-Hodgkin lymphoma typically involves the biopsy of suspicious lymph nodes or extranodal tumors, where the normal tissue architecture is replaced by sheets of large cells exhibiting positive staining for pan-B-cell antigens, like CD20 and CD79a [2]. The gene discussed is CD79A; the disease is non-Hodgkin lymphoma.